These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31645895)

  • 1. Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development.
    Molina L; Yang H; Michael AOA; Oertel M; Bell A; Singh S; Chen X; Tao J; Monga SP
    Oncotarget; 2019 Sep; 10(54):5670. PubMed ID: 31645895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development.
    Molina L; Yang H; Adebayo Michael AO; Oertel M; Bell A; Singh S; Chen X; Tao J; Monga SPS
    Oncotarget; 2019 Feb; 10(15):1475-1490. PubMed ID: 30863496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.
    Arend RC; Londoño-Joshi AI; Gangrade A; Katre AA; Kurpad C; Li Y; Samant RS; Li PK; Landen CN; Yang ES; Hidalgo B; Alvarez RD; Straughn JM; Forero A; Buchsbaum DJ
    Oncotarget; 2018 Apr; 9(27):19459. PubMed ID: 29721216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
    Sha YL; Liu S; Yan WW; Dong B
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31511432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy.
    Bucher F; Friedlander M; Yea K
    Oncotarget; 2018 Sep; 9(69):33244. PubMed ID: 30237865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix.
    Mann M; Kumar S; Chauhan SS; Bhatla N; Kumar S; Bakhshi S; Gupta R; Sharma A; Kumar L
    Oncotarget; 2019 Jul; 10(46):4802. PubMed ID: 31413820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Inhibition of neddylation regulates dendritic cell functions
    Cheng M; Hu S; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J
    Oncotarget; 2018 Dec; 9(99):37343. PubMed ID: 30647874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Dishevelled1-3 contribute to multidrug resistance in colorectal cancer via activating Wnt/β-catenin signaling.
    Zhang K; Li M; Huang H; Li L; Yang J; Feng L; Gou J; Jiang M; Peng L; Chen L; Li T; Yang P; Yang Y; Wang Y; Peng Q; Dai X; Zhang T
    Oncotarget; 2021 Nov; 12(24):2434. PubMed ID: 34853664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine.
    Jung DB; Yun M; Kim EO; Kim J; Kim B; Jung JH; Wang E; Mukopadhyay D; Hammond E; Dredge K; Shridhar V; Kim SH
    Oncotarget; 2019 Sep; 10(54):5669. PubMed ID: 31608142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma.
    Molina L; Bell D; Tao J; Preziosi M; Pradhan-Sundd T; Singh S; Poddar M; Luo J; Ranganathan S; Chikina M; Monga SP
    Am J Pathol; 2018 Aug; 188(8):1895-1909. PubMed ID: 29920228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt, RSPO and Hippo Signalling in the Intestine and Intestinal Stem Cells.
    Kriz V; Korinek V
    Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29316729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6/YAP1/β-catenin signaling is involved in intervertebral disc degeneration.
    Chen J; Mei Z; Huang B; Zhang X; Liu J; Shan Z; Wang J; Wang X; Zhao F
    J Cell Physiol; 2019 May; 234(5):5964-5971. PubMed ID: 30511395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis
    Yang H; Guan L; Li S; Jiang Y; Xiong N; Li L; Wu C; Zeng H; Liu Y
    Oncotarget; 2018 Aug; 9(66):32730. PubMed ID: 30220978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
    Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
    Oncotarget; 2018 Feb; 9(15):12534. PubMed ID: 29552331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity
    Shi F; Zhang J; Liu H; Wu L; Jiang H; Wu Q; Liu T; Lou M; Wu H
    Oncotarget; 2018 Mar; 9(24):17255. PubMed ID: 29683149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expressions of YAP1, β-catenin and survivin in colon cancer tissues and their clinical significance.
    Shao Q; Xu J; Deng R; Wei W; Zhou B; Yue C; Zhu M; Zhu H
    Int J Clin Exp Pathol; 2018; 11(12):6032-6038. PubMed ID: 31949692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1.
    Sekihara K; Saitoh K; Han L; Ciurea S; Yamamoto S; Kikkawa M; Kazuno S; Taka H; Kaga N; Arai H; Miida T; Andreeff M; Konopleva M; Tabe Y
    Oncotarget; 2019 Nov; 10(63):6842. PubMed ID: 31827726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic KRAS signaling and YAP1/β-catenin: Similar cell cycle control in tumor initiation.
    Nussinov R; Tsai CJ; Jang H; Korcsmáros T; Csermely P
    Semin Cell Dev Biol; 2016 Oct; 58():79-85. PubMed ID: 27058752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.
    Guan B; Wu K; Zeng J; Xu S; Mu L; Gao Y; Wang K; Ma Z; Tian J; Shi Q; Guo P; Wang X; He D; Du Y
    Oncotarget; 2022; 13():507. PubMed ID: 35284038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.